| Date | Time | Source | Headline | Symbol | Company |
| 01/24/2022 | 9:53AM | Alliance News |  MaxCyte expects improved full-year revenue on organic growth | LSE:MXCT | Maxcyte Inc |
| 01/24/2022 | 3:02AM | Alliance News | *MaxCyte expects FY revenue above USD33.7m up from USD26.2m yoy | LSE:MXCT | Maxcyte Inc |
| 01/24/2022 | 3:01AM | Alliance News | *MaxCyte expects fourth-quarter revenue to be greater than USD10m | LSE:MXCT | Maxcyte Inc |
| 01/24/2022 | 2:30AM | UK Regulatory | MaxCyte, Inc. Preliminary Unaudited Q4 & FY 2021 Revenue Results | LSE:MXCT | Maxcyte Inc |
| 12/29/2021 | 10:29AM | UK Regulatory | MaxCyte, Inc. Holdings in Company | LSE:MXCT | Maxcyte Inc |
| 12/01/2021 | 11:59AM | UK Regulatory | MaxCyte, Inc. Total Voting Rights | LSE:MXCT | Maxcyte Inc |
| 11/23/2021 | 11:21AM | Alliance News | DIRECTOR DEALINGS: New MaxCyte chair buys USD220,000 in shares | LSE:MXCT | Maxcyte Inc |
| 11/23/2021 | 2:32AM | UK Regulatory | MaxCyte, Inc. Purchase of Common Stock | LSE:MXCT | Maxcyte Inc |
| 11/17/2021 | 12:36PM | UK Regulatory | MaxCyte, Inc. Exercise of options and PDMR Dealing | LSE:MXCT | Maxcyte Inc |
| 11/11/2021 | 4:26PM | Alliance News | TRADING UPDATES: iEnergizer and Volex post interim profit hikes | LSE:MXCT | Maxcyte Inc |
| 11/11/2021 | 2:00AM | UK Regulatory | MaxCyte, Inc. MaxCyte Reports Third Quarter Financial Results | LSE:MXCT | Maxcyte Inc |
| 11/10/2021 | 4:00PM | PR Newswire (US) | MaxCyte Reports Third Quarter Financial Results | LSE:MXCT | Maxcyte Inc |
| 11/03/2021 | 10:13AM | Alliance News | EXECUTIVE CHANGES: MaxCyte promotes to chair; Sanderson adds retailers | LSE:MXCT | Maxcyte Inc |
| 11/03/2021 | 8:59AM | UK Regulatory | MaxCyte, Inc. Appointment of Chairman of the Board | LSE:MXCT | Maxcyte Inc |
| 10/29/2021 | 4:20PM | Alliance News | TRADING UPDATES: Mattioli outlook promising; virus hits Grand Vision | LSE:MXCT | Maxcyte Inc |
| 10/29/2021 | 12:03PM | Alliance News | *MaxCyte says all AGM resolutions passed except proposal 2 | LSE:MXCT | Maxcyte Inc |
| 10/29/2021 | 12:01PM | UK Regulatory | MaxCyte, Inc. Result of AGM | LSE:MXCT | Maxcyte Inc |
| 10/28/2021 | 2:19PM | Alliance News | TRADING UPDATES: Hunting hurt by Ida; React revenue short of consensus | LSE:MXCT | Maxcyte Inc |
| 10/28/2021 | 10:00AM | UK Regulatory | MaxCyte, Inc. License with Nkarta, Inc. | LSE:MXCT | Maxcyte Inc |
| 10/26/2021 | 2:00AM | UK Regulatory | MaxCyte, Inc. Notice of Results | LSE:MXCT | Maxcyte Inc |
| 10/06/2021 | 2:00AM | UK Regulatory | MaxCyte, Inc. Holdings in Company | LSE:MXCT | Maxcyte Inc |
| 10/01/2021 | 12:55PM | Alliance News | IN BRIEF: MaxCyte Chair Thompson to step down late October | LSE:MXCT | Maxcyte Inc |
| 10/01/2021 | 10:48AM | UK Regulatory | MaxCyte, Inc. Notice of AGM and Change of Director | LSE:MXCT | Maxcyte Inc |
| 10/01/2021 | 7:36AM | UK Regulatory | MaxCyte, Inc. Total Voting Rights | LSE:MXCT | Maxcyte Inc |
| 09/17/2021 | 12:50PM | Alliance News | IN BRIEF: MaxCyte to join Russell 2000 index in US on September 20 | LSE:MXCT | Maxcyte Inc |
| 09/17/2021 | 9:34AM | RNS Non-Regulatory | MaxCyte, Inc. MaxCyte Set to Join Russell 2000(R) Index | LSE:MXCT | Maxcyte Inc |
| 09/14/2021 | 12:46PM | Alliance News | TRADING UPDATES: Strong annual results from Springfield, Fiske | LSE:MXCT | Maxcyte Inc |
| 09/14/2021 | 2:00AM | UK Regulatory | MaxCyte, Inc. Half-year Report | LSE:MXCT | Maxcyte Inc |
| 09/14/2021 | 2:00AM | UK Regulatory | MaxCyte, Inc. Filing of Form 10-Q | LSE:MXCT | Maxcyte Inc |
| 09/13/2021 | 5:50PM | PR Newswire (US) | MaxCyte announces filing of Form 10-Q for the quarterly period ended June 30, 2021 | LSE:MXCT | Maxcyte Inc |